期刊文献+

NF-κBP65和caspase-3在中耳胆脂瘤中的表达及其临床意义 被引量:4

Expression of NF-κB and caspase-3 in middle ear cholesteatoma and its clinical significance
下载PDF
导出
摘要 目的研究NF-κB P65和caspase-3在中耳胆脂瘤中的表达及意义。方法应用免疫组织化学方法检测30例胆脂瘤上皮组织(胆脂瘤组)及10例正常外耳道皮肤组织(对照组)中NF-κB P65和caspase-3蛋白的表达情况,并采用图像分析系统对表达结果进行定量分析。结果免疫组化染色显示胆脂瘤上皮组织中NF-κB P65表达阳性率显著高于正常上皮组织,两组比较差异有统计学意义(P<0.05),其阳性单位分别为27.90±9.13和13.23±9.05,两组间比较差异有统计学意义(t=4.307,P<0.05);胆脂瘤上皮组织中caspase-3表达阳性率显著高于正常上皮组织(P<0.05),其阳性单位分别为17.29±6.21和8.31±3.44,两组间比较差异有统计学意义(t=4.287,P<0.05)。胆脂瘤上皮中NF-κB P65与caspase-3表达无相关性(r=0.01,P=0.961)。结论 NF-κB P65与caspase-3过表达可能与中耳胆脂瘤的发生和发展有关,其可能参与了中耳胆脂瘤上皮细胞的增殖及过度凋亡的调控。 Objective To explore the expression of NF-κB P65 and caspase-3 in middle ear cholesteatoma and its significance.Methods The expression of NF-κB P65 and caspase-3 protein in 30 cases of middle ear cholesteatoma and 10 cases of normal external acoustic meatus skin was detected using immunohistochemical staining method and quantitative analysis of image.Results The positive expression rates of NF-κB P65 protein and caspase-3 were significantly different between two groups(P〈0.05).The positive units(PU) of expression of NF-κB P65 protein were 27.90±9.13 in middle ear cholesteatoma and 13.23±9.05 in normal external acoustic meatus skin(t=4.307,P〈0.05).The positive units(PU) of expression of caspase-3 protein were 17.29±6.21 in middle ear cholesteatoma and 8.31±3.44 in normal external acoustic meatus skin(t=4.287,P〈0.05).The expression of NF-κB P65 was not correlated with expression of caspase-3(r=0.01,P=0.961).Conclusion The overexpression of NF-κB P65 and caspase-3 may involve in the formation and development of middle ear cholesteatoma by regulating apoptosis and cell proliferation.
出处 《山西医科大学学报》 CAS 2011年第4期288-291,共4页 Journal of Shanxi Medical University
关键词 胆脂瘤 NF-ΚB CASPASE-3 免疫组织化学 cholesteatoma NF-κB caspase-3 immunohistochemistry
  • 相关文献

参考文献8

  • 1Ghosh S,Karin M.Missing pieces in the NF-kappaB puzzle[J].Cell,2002,109(Suppl):S81-96.
  • 2Inoue J,Gohda J,Akiyama T,et al.NF-kappaB activation in develo-pment and progression of cancer[J].Cancer Sci,2007,98(3):268-274.
  • 3Barrett TQ,Kristiansen LH,Ovesen T.NF-kappaB in cultivated middle ear epithelium[J].Int J Pediatr Otorhinolaryngol,2003,67(8):895-903.
  • 4Ovesen T,Barrett TQ.Nuclear factor-kappaB in middle ear epithelial cells:a methodological study using an ELISA[J].Acta Otolaryngol,2003,123(2):306-309.
  • 5Sohn SJ.Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors[J].Acta OtoLaryngol,2005,125(2):130-133.
  • 6Sanda T,Asamitsu K,Ogura H,et al.Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor[J].Leukemia,2006,20(4):590-598.
  • 7Ergun S,Carlsoo B,Zheng X.Apoptosis in meatal skin,cholesteatoma and squamous cellcarcinoma of the ear[J].Clin Otolaryngol Allied Sci,1999,24(4):280-285.
  • 8Kojima H,Tanaka Y,Tanaka T,et al.Cell proliferation and apoptosis in human middle ear cholesteatoma[J].Arch Otolaryngol Head Neck Surg,1998,124(3):261-264.

同被引文献75

  • 1王辉兵,徐志文,唐安洲,苏纪平.中耳胆脂瘤基质金属蛋白酶2,9的活性检测及临床意义[J].临床耳鼻咽喉科杂志,2004,18(10):620-622. 被引量:14
  • 2李冬,黄芳,龚树生,张鄂.凋亡抑制蛋白Survivin及Bcl-2在中耳胆脂瘤上皮中的表达及意义[J].中国耳鼻咽喉颅底外科杂志,2006,12(5):334-338. 被引量:9
  • 3Helgaland T, Engelen B, Olsnes C, et al. In vitro cholesteatomagrowth and secreti on of cytokines. Acta Otolaryngol,2010, 130(7): 815-819.
  • 4Weber C, Schober A, Zemecke A. Chemokines : key regulatorsof mononuclear cell recruitment in atherosclerotic vascular disease.Arterioscler Thromb Vase Biol, 2004,24 (11) : 1997-2008.
  • 5Kumar SN, Boss JM. Site A of the MCP-1 distal regulatory regionfunctions as a transcriptional modulator through the transcriptionfactor NF1. Mol Immunol. 2000, 37 (11) : 623-632.
  • 6Jiang Y, Beller DI, FrendlG,et al. Monocyte chemoattractantprotein-1 regulates adhesion molecule expression and cytokineproduction in human monocytes. J Immunol, 1992, 148 (8):2423-2428.
  • 7Kuczkowski J, Sakowicz-Burkiewicz M,Izycka-wieszewskaE,et al. Expression of tumor necrosis factor-a, interleukin-la,interleukin-6 and interleukin-10 in chronic otitis media withbone osteolysis. ORL J Otorhinolaryngol Relat Spec, 2011,73(2): 93-99.
  • 8Peek FA , Huisman MA , Berckmans RJ,et al.Lipopolysaccharide concentration and bone resorption incholesteatoma, Otol Neurotol, 2003,24 (5) : 709-713.
  • 9Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci,2002, 115 (20) : 3861-3863.
  • 10Sudhoff H, Bujia J, Borkowshi G,et al. Basement membranein middle ear cholesteatoma. Immunohistochemical andultrastructural observations. Ann Otol Rhinol Laryngol, 1996,105 (10) : 804-810.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部